The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Seems to be well up on little volume & mms have a hunger for shares. Leak?
Would be nice to see Bleepa added to this list. Interesting read re expansion of rural facilities.
https://www.fortuneindia.com/enterprise/how-doctco-qureai-moms-belief-babyready-are-building-healthcare-for-bharat/106252
It's showing (as are the two trades after) as and ECHO trade publication. It's most likely an off book transfer of shares from one party to another. Doesn't seem to have influenced the SP one way or the other.
Okay it's sponsored by Bleepa but still an interesting read...
https://www.hsj.co.uk/service-design/cdcs-alone-wont-ease-the-elective-care-backlog/7031396.article
Well the market doesn't seem to like that news, either that or it's a flurry of impatient punters. I'm still holding and haven't sold a bean and like most back underwater again. I'm hanging in for the bigger picture to emerge and of all my holdings I still think this has the most potential. If as Bleepa say, they are the ONLY certified messaging device, I can't see how they won't be involved in a big way with this digital transformation the NHS is about to go through.
Another bit here about the merger: https://www.digitalhealth.net/2021/11/nhs-digital-nhsx-merge-nhs-england/
“As a single organisation, we can further accelerate the digital transformation of the NHS and redouble our efforts to address health inequalities,”
Secretary of state for health and social care, Sajid Javid, said: “To ensure our record NHS investment makes a lasting impact, I am bringing workforce planning and digital transformation into the heart of the NHS.
“These reforms will support our recovery from Covid-19 and help us tackle waiting lists to give patients excellent care in years to come."
Qure.ai at it again. - Of course what they really need in this scenario is Carelocker!
https://economictimes.indiatimes.com/tech/tech-bytes/medanta-partners-with-qure-ai-for-ai-enabled-x-ray-deployment/articleshow/87883067.cms
Mmmm this is interesting; https://mobile.twitter.com/HINSouthLondon/status/1463150364753121285
London CDCs in the bag too?
I've asked for approx 25% more than I'm entitled too but not expecting to get them. With HL and funds still haven't been taken yet although they did say sometime 24th for 25th.
Meanwhile Qure.ai continues to expand: https://www.mobihealthnews.com/news/asia/qureai-rolls-out-ai-stroke-management-platform?utm_source=dlvr.it&utm_medium=twitter
Nice one Vas, Wonder what involvement bleepa has. 8th December not far off
On further inspection they're on the same accelerator scheme. Maybe something and nothing.
https://thejournalofmhealth.com/vantage-health-joins-latest-digitalhealth-london-accelerator-cohort/amp/
Whilst we're at it... If you search "bleepa" on the main search provider and narrow it down to last 7 days. Vantage Health is listed as 3 days ago via linkedin. I'm not a member so can't investigate further but interesting that it's an medical AI company.
Nice find. Quite like this bit : “Electronic Patient Record systems are the building blocks of good digital healthcare, but they are also complex and expensive to procure. At NHSX, we want to positively shape the EPR market in England and help local NHS organisations procure new, modern solutions and drive wider innovation in the market,” Sonia Patel, CIO at NHSX said. Carelocker anyone?
I can't sell more than 50k yet someone had to pay over the odds at 1.10 for 250k. Lr2.... Any idea what the limits are?
Wilf, have a look at the links Ragnarr posted yesterday. You'll have to make you're own mind up although it looks nailed on to me. The only thing that isn't clear is what proportion of the 360m contact belongs to bleepa. Wouldn't want to be out at the moment though. GLA
Ragnarr.... Your selfishness knows no bounds lol... Great find again, almost tempted to buy more!
Ragnarr.... You're on fire! Great research and I'm sure I speak for everyone in saying thanks.
And another 1 trade, although the last one came to nothing.
Nice find. Can't see how it wouldn't get the go ahead and why bleepa wouldn't be involved.
... a 1 trade at 9.49.
Holding up quite well and can see it going nuts on any contract news/further expansion of the CDC program.